查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1928588

非洲猪瘟病毒抗体检测ELISA试剂盒市场（按产品类型、检测类型、检体类型、通路、应用和最终用户划分），全球预测，2026-2032年

ELISA Kit for Antibody Detection Against African Swine Fever Virus Market by Product Type, Test Type, Sample Type, Distribution Channel, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年非洲猪瘟病毒抗体检测 ELISA 试剂盒市值为 7,012 万美元，预计到 2026 年将成长至 8,047 万美元，复合年增长率为 6.48%，到 2032 年将达到 1.0884 亿美元。

关键市场统计数据
基准年 2025 7012万美元
预计年份：2026年 8047万美元
预测年份 2032 1.0884亿美元
复合年增长率 (%) 6.48%

本文清楚概述了抗体ELISA诊断为何是现代非洲猪瘟病毒检测策略和相关人员决策架构的核心。

非洲猪瘟病毒 (ASFV) 仍然是动物卫生系统面临的持续性挑战，因此基于抗体的ELISA检验对于制定全面的检测策略至关重要。本文将竞争性 ELISA、间接 ELISA 和夹心 ELISA 等检测方法在实验室工作流程中的诊断作用置于中心位置，并阐明检测方法的选择如何与监测目标、研究重点和疫苗项目开发相关联。随着应对疫情的策略从孤立的疫情应对转向综合监测和防范，抗体 ELISA 平台如今已与分子诊断、血清流行病学和现场检测方法并行运作。

对近期由技术、政策和合作主导的变革如何重塑非洲猪瘟病毒抗体ELISA检测生态系统和诊断供应链进行了深入分析。

过去几年，受技术进步、政策调整和动物健康优先事项转变的推动，非洲猪瘟病毒（ASFV）的诊断格局发生了翻天覆地的变化。高通量检查室自动化和试剂化学的改进提高了竞争性、间接和夹心ELISA检测的可靠性和可重复性，使检查室能够以更高的置信度处理更多检体。同时，数位化整合和检查室资讯管理系统简化了诊断检查室、政府监测部门和研究中心之间的资料流，提高了公共卫生应对和政策决策的灵活性。

对近期美国关税调整对非洲猪瘟病毒抗体ELISA生态系统的采购、供应链策略和供应商选择的影响进行全面检验

美国近期实施和调整关税所产生的累积效应远不止于即时的成本调整，也影响筹资策略、供应链韧性和供应商选择。进口试剂和检测试剂盒关税的提高促使一些实验室和政府采购机构使其供应商组合多元化，重新评估长期采购合同，并纳入更严格的总体拥有成本分析，将物流成本、前置作业时间和本地检验成本纳入考虑。这些变化也促使製造商和经销商重新评估其区域定价和分销模式，加快对本地仓库和伙伴关係网络的投资，以减轻关税的影响并降低政策突变带来的风险。

基于全面细分的解读详细说明了测试类型、最终用户、应用程式和分销管道如何共同影响检测设计、采购和部署趋势。

对市场区隔的深入理解揭示了需求、技术要求和分销挑战相互交织的领域，这些交织共同塑造了产品策略。按检测类型划分，竞争性的 ELISA、间接 ELISA 和夹心 ELISA 各自具有不同的性能特征和工作流程影响，检查室的偏好和临床应用。製造商必须优化检测的灵敏度、特异性和易用性，以满足这些操作限制。按最终用户划分，诊断检查室、政府机构、研究机构和兽医诊所各自具有独特的检验要求、通量和监管需求。尤其是在诊断检查室内部，私营和公共部门的细分市场在采购行为和服务期望方面存在差异。按应用划分，疾病诊断、研发、监测和疫苗开发都需要专门的试剂盒功能、品质文件和支援服务。在监测领域，主动监测和被动监测的差异导致检体处理、推广物流和报告频率方面的差异。根据分销管道的不同，直销、分销商和线上管道决定了交货速度和成本，而国际分销商和国内分销商之间的区别则影响前置作业时间、监管支援和售后服务。

区域战略洞察：美洲、欧洲、中东和非洲以及亚太地区如何各自形成不同的ELISA诊断监管、采购和分销要求

区域趋势在决定非洲猪瘟病毒抗体ELISA检测的推广时间表、监管重点和流通结构发挥着至关重要的作用。在美洲，各国法规结构的差异以及大规模的商业猪场催生了对扩充性检查室解决方案的强劲需求。然而，广袤地域带来的物流复杂性进一步凸显了区域分销中心和技术支援网路的重要性。因此，专注于该地区的供应商强调供应链的稳健性和全面的验证方案，以满足商业养殖场和公共卫生监测的需求。在欧洲、中东和非洲，不同的管理体制和兽医基础设施要求供应商采取灵活的市场进入策略。有些市场需要与政府机构密切合作进行监测项目，而有些市场则依赖私人实验室和兽医诊所进行疫情管理。在该地区运营的供应商必须平衡监管合规性与当地检查室能力和培训需求。在亚太地区，密集的生产基地、跨境动物疾病的高发生率以及快速发展的检测能力正在推动对高通量平台和照护现场ELISA试剂盒的需求。此外，跨境贸易考量和区域合作倡议正日益影响筹资策略和测试标准化工作的优先顺序。

对公司和机构进行深入评估，以确定製造商、经销商和合作伙伴关係如何透过检验、供应连续性和支援服务来创造竞争优势。

非洲猪瘟病毒抗体ELISA领域的主要企业因其提供检验的检测性能、可靠的供应链和一体化的支援服务而备受认可。提供多种ELISA检测形式的成熟厂商透过提供全面的技术文件、交叉检验数据和扩充性的生产能力来满足紧急监测需求，从而展现出竞争优势。同时，新兴创新者提供专门的检测化学方法、简化的使用者介面或模组化平台，以便在资源有限的环境和兽医诊所中实施。经销商和物流合作伙伴发挥着至关重要的作用，他们确保跨多个司法管辖区的低温运输完整性、及时交付和监管支持，使厂商能够覆盖分散的检测点。

为製造商、经销商和相关人员提供切实可行的策略建议，以加速抗体 ELISA 检测的普及应用，并加强检验、供应链韧性和支援服务。

产业领导者应采取多管齐下的策略，以加速非洲猪瘟病毒抗体ELISA诊断试剂盒的推广应用，并增强营运韧性。首先，透过投资完善的检验和文件编制，使检测性能符合监管要求和检查室认证标准，从而降低公立和私立诊断检查室的采购门槛。其次，透过在关键市场开展直销，并与国内外经销商建立策略合作伙伴关係，实现分销网络多元化，从而降低海关风险并缩短前置作业时间。第三，拓展支援服务，包括现场和远端培训、与检查室资讯系统整合以及上市后检测性能监测，以建立与政府机构和研究机构的信任。

一项透明的混合方法调查方法详细介绍了用于深入了解 ELISA 诊断的采用和部署的初步访谈、二次检验和分析框架。

本报告结合质性研究和一手调查方法，以确保得出可靠且基于证据的结论。一手资料来自对诊断检查室主任、政府监管管理人员、兽医和科研人员的结构化访谈，并辅以供应商巡迴推介和经销商评估，以了解实际采购和物流方面的考量。二手分析整合了同侪审查文献、监管指导文件和技术检验报告，以检验竞争性、间接和夹心ELISA方法的性能特征。

总之，这份简要总结强调了适应性检验、供应链韧性和协作部署策略对于优化基于 ELISA 的非洲猪瘟病毒抗体检测的重要性。

总之，非洲猪瘟病毒（ASFV）抗体ELISA诊断在现代监测、诊断和控制体系中占据着至关重要的地位。检测化学技术的进步、采购趋势的转变以及各地区监管环境的差异，都要求製造商、经销商和最终用户采取适应性策略，优先考虑检验、供应连续性和客製化支援。按检测类型、最终用户、应用和通路进行细分，可以突显产品差异化和增强服务在推动产品应用方面最为有效的领域。同时，区域差异也凸显了製定客製化监管和物流方案的必要性。将知识转化为实践需要产业、政府和研究机构的共同努力，以确保检测能够在各种实验室和现场环境的操作限制下提供可靠的结果。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 非洲猪瘟病毒抗体检测ELISA试剂盒市场（依产品类型划分）

  • 间接ELISA试剂盒
    • IgG抗体检测
    • 总抗体检测
  • 阻断与竞争性ELISA试剂盒
    • 基于单株抗体的
    • 基于多株抗体
  • 双抗原夹心ELISA试剂盒

9. 非洲猪瘟病毒抗体检测ELISA试剂盒市场（依检测类型划分）

  • 竞争性ELISA
  • 间接ELISA
  • 夹心ELISA

第十章 非洲猪瘟病毒抗体检测ELISA试剂盒市场（依检体类型划分）

  • 血清样本
    • 个体动物血清
    • 混合血清
  • 血浆样本
  • 全血
  • 口腔液
  • 组织萃取物

第十一章 非洲猪瘟病毒抗体检测ELISA试剂盒市场（依通路划分）

  • 直销
  • 经销商
    • 国际经销商
    • 国内经销商
  • 在线的

第十二章 非洲猪瘟病毒抗体检测ELISA试剂盒市场（依应用划分）

  • 疾病诊断
  • 调查
  • 监测
    • 主动监测
    • 被动监测
  • 疫苗研发

第十三章 非洲猪瘟病毒抗体检测ELISA试剂盒市场（依最终用户划分）

  • 诊断实验室
    • 私人的
    • 公共机构
  • 政府机构
  • 研究所
  • 兽医院

14. 非洲猪瘟病毒抗体检测ELISA试剂盒市场（依地区分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 非洲猪瘟病毒抗体检测ELISA试剂盒市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

16. 非洲猪瘟病毒抗体检测ELISA试剂盒市场（依国家划分）

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

17. 美国：非洲猪瘟病毒抗体检测ELISA试剂盒市场

18. 中国：非洲猪瘟病毒抗体检测ELISA试剂盒市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abcam plc
  • Adiagen, Inc.
  • Bionote, Inc.
  • Biosellal SA
  • BioStone Animal Health LLC
  • Boehringer Ingelheim Svanova
  • Cusabio Biotech Co., Ltd.
  • Gold Standard Diagnostics, Inc.
  • ID.vet Innovative Diagnostics
  • IDEXX Laboratories, Inc.
  • Indical Bioscience GmbH
  • J&G Biotech Ltd.
  • Merck KGaA
  • R&D Systems, Inc.
  • Tetracore, Inc.
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-92740D85F050

The ELISA Kit for Antibody Detection Against African Swine Fever Virus Market was valued at USD 70.12 million in 2025 and is projected to grow to USD 80.47 million in 2026, with a CAGR of 6.48%, reaching USD 108.84 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 70.12 million
Estimated Year [2026] USD 80.47 million
Forecast Year [2032] USD 108.84 million
CAGR (%) 6.48%

Clear foundational overview emphasizing why antibody ELISA diagnostics are central to modern African Swine Fever virus detection strategies and stakeholder decision frameworks

African Swine Fever Virus (ASFV) continues to present a persistent challenge across animal health systems, and antibody-based ELISA assays have become integral to comprehensive detection strategies. This introduction frames the diagnostic role of Competitive ELISA, Indirect ELISA, and Sandwich ELISA formats within laboratory workflows and highlights how assay selection intersects with surveillance objectives, research priorities, and vaccine program development. The landscape has shifted from isolated outbreak response toward integrated surveillance and preparedness, and antibody ELISA platforms now operate alongside molecular diagnostics, seroepidemiology, and field-based testing modalities.

In practical terms, diagnostic laboratories, government agencies, research institutions, and veterinary hospitals encounter distinct operational requirements that drive procurement, validation, and deployment decisions. Diagnostic laboratories must balance throughput and specificity while government agencies focus on surveillance sensitivity and traceability. Research institutions prioritize assay flexibility for experimental designs, and veterinary hospitals emphasize rapid clinical decision support. As a result, product design, regulatory strategy, and distribution models all evolve to meet these varied end-user needs. Consequently, stakeholders must appreciate the technical nuance of assay formats and align procurement and validation pathways to local and international regulatory expectations.

Insightful analysis of the recent technological, policy and collaboration-driven transitions reshaping African Swine Fever virus antibody ELISA testing ecosystems and diagnostic supply chains

Over the last several years, the diagnostics environment for ASFV has undergone transformative shifts driven by technological advances, policy recalibration, and changing animal health priorities. High-throughput laboratory automation and improved reagent chemistries have increased the reliability and reproducibility of Competitive, Indirect, and Sandwich ELISA formats, enabling laboratories to process larger sample volumes with greater confidence. At the same time, digital integration and laboratory information management systems have streamlined data flows between diagnostic laboratories, government surveillance units, and research centers, improving the timeliness of public health responses and policy decisions.

Moreover, the industry has adapted to a more collaborative posture between public and private actors. Government agencies and research institutions now share validation protocols and reference materials more readily, which accelerates assay adoption and harmonizes performance expectations. This shift is further reinforced by increasing emphasis on One Health principles that recognize the interplay between veterinary diagnostics, epidemiology, and agricultural economics. Consequently, manufacturers and distributors are redesigning their value propositions to emphasize end-to-end service, including technical support, training, and integration with surveillance programs, rather than focusing solely on reagent supply.

Comprehensive examination of how recent United States tariff adjustments have reshaped procurement, supply chain strategies, and vendor selection across the antibody ELISA ecosystem for African Swine Fever virus

The recent imposition and recalibration of tariffs within the United States have created cumulative effects that extend beyond immediate cost adjustments to influence procurement strategies, supply chain resilience, and vendor selection. Increased duties on imported reagents and assay kits have encouraged some laboratories and government procurement bodies to diversify supplier portfolios and to re-evaluate long-term sourcing arrangements, integrating more rigorous total-cost-of-ownership analyses that factor in logistical overheads, lead times, and local validation expenses. These dynamics have also prompted manufacturers and distributors to revisit their regional pricing and distribution models, accelerating investments in local warehousing and partnership networks to mitigate tariff impacts and reduce exposure to sudden policy shifts.

As a consequence, end users increasingly demand greater transparency in pricing breakdowns and continuity guarantees, while procurement teams prioritize vendors with demonstrated regional presence or established national distribution channels. Research institutions have faced similar pressures; they now place higher value on suppliers that provide robust technical documentation and training during assay transfer processes. Transitioning from reactive adjustments to proactive supply chain design has become essential, and stakeholders who adopt adaptive procurement frameworks position themselves to maintain testing continuity despite regulatory and tariff-related turbulence.

Holistic segmentation-driven interpretation detailing how test types, end users, applications, and distribution channels collectively determine assay design, procurement and deployment dynamics

A granular understanding of market segmentation illuminates where demand, technical requirements, and distribution challenges converge to shape product strategies. Based on Test Type, Competitive ELISA, Indirect ELISA, and Sandwich ELISA offer distinct performance characteristics and workflow implications that influence laboratory preference and clinical application; manufacturers must therefore optimize assay sensitivity, specificity, and ease of use to fit those operational constraints. Based on End User, Diagnostic Laboratories, Government Agencies, Research Institutions, and Veterinary Hospitals each bring unique validation, throughput, and regulatory needs, and within Diagnostic Laboratories the private and public subsegments demonstrate divergent purchasing behaviors and service expectations. Based on Application, Disease Diagnosis, Research, Surveillance, and Vaccine Development require tailored kit features, quality documentation, and support services, and within Surveillance the split between Active Surveillance and Passive Surveillance drives differences in sample handling, outreach logistics, and reporting cadences. Based on Distribution Channel, Direct Sales, Distributors, and Online channels determine the speed and cost of delivery, while the differentiation between International Distributors and National Distributors affects lead times, regulatory assistance, and after-sales support.

This segmentation framework reveals multiple commercial levers. For example, products engineered to meet the throughput demands of public diagnostic laboratories will differ in format and documentation from kits designed for research laboratories seeking flexible assay conditions. Similarly, surveillance-focused deployments require robust supply continuity and clear chain-of-custody features, whereas veterinary hospitals prioritize rapid clinical turnaround and simplified workflows. Distribution strategy must therefore align with end-user expectations; manufacturers that refine channel approaches to provide both direct engagement and strong distributor partnerships can reduce friction and increase adoption across diverse user groups.

Strategic regional insights explaining how the Americas, Europe Middle East & Africa, and Asia-Pacific each shape differentiated regulatory, procurement and distribution imperatives for ELISA diagnostics

Regional dynamics play a decisive role in shaping adoption timelines, regulatory priorities, and distribution architectures for ASFV antibody ELISA assays. In the Americas, varied national regulatory frameworks and large-scale commercial swine operations create a strong demand for scalable laboratory solutions, yet logistical complexity across wide geographies also heightens the importance of local distribution hubs and technical support networks. Consequently, vendors focusing on this region emphasize supply chain robustness and comprehensive validation packages to meet both commercial farm and public health surveillance needs. In Europe, Middle East & Africa, heterogeneous regulatory regimes and diverse veterinary infrastructures require adaptable go-to-market approaches; some markets demand close collaboration with government agencies for surveillance programs, while others rely on private diagnostic laboratories and veterinary clinics for outbreak management. Suppliers operating here must balance regulatory conformity with sensitivity to local laboratory capabilities and training needs. In the Asia-Pacific region, dense production hubs, a high incidence of transboundary animal disease concerns, and rapidly advancing laboratory capacity drive demand for both high-throughput platforms and point-of-care compatible ELISA kits. In addition, cross-border trade considerations and regional cooperation initiatives increasingly inform procurement strategies and the prioritization of assay standardization efforts.

Taken together, these regional characteristics indicate that a single global distribution or product strategy will rarely suffice. Instead, successful market engagement depends on tailoring regulatory dossiers, technical support, and logistics models to regional realities, while fostering partnerships with local distributors, laboratories, and government stakeholders to enable rapid, reliable adoption.

In-depth corporate and institutional appraisal identifying how manufacturers, distributors, and collaborative partnerships create competitive differentiation through validation, supply continuity and support services

Key corporate players and institutional actors in the ASFV antibody ELISA space are increasingly evaluated on their ability to deliver validated assay performance, reliable supply chains, and integrated support services. Established manufacturers that offer multiple ELISA formats demonstrate competitive advantage when they provide comprehensive technical dossiers, cross-validation data, and scalable manufacturing to accommodate urgent surveillance needs. At the same time, emerging innovators contribute specialized assay chemistries, simplified user interfaces, or modular platforms that ease deployment in resource-limited settings and veterinary clinics. Distributors and logistics partners play a pivotal role by ensuring cold-chain integrity, timely delivery, and regulatory support across multiple jurisdictions, thereby enabling manufacturers to reach decentralized testing sites.

Institutional collaborations between commercial firms and research institutions or government agencies have increased, and these partnerships frequently yield shared reference standards, co-developed validation protocols, and training programs that accelerate market entry. As procurement officers place higher value on end-to-end solutions, companies that bundle assays with validation services, digital data integration, and on-the-ground technical assistance achieve higher adoption rates. Ultimately, competitive differentiation now rests on a combination of technical excellence, demonstrable regulatory compliance, and the ability to sustain uninterrupted supply in varied regional contexts.

Actionable strategic recommendations for manufacturers, distributors and stakeholders to accelerate adoption of antibody ELISA assays while strengthening validation, supply resilience and support services

Industry leaders should pursue a multi-pronged strategy to enhance adoption of ASFV antibody ELISA diagnostics while strengthening operational resilience. First, invest in robust validation and documentation that align assay performance with regulatory expectations and laboratory accreditation standards, thereby lowering barriers for procurement across public and private diagnostic laboratories. Second, diversify distribution footprints by combining direct sales in core markets with strategic partnerships with national and international distributors to reduce tariff exposure and improve lead times. Third, expand support services to include on-site or remote training, integration with laboratory information systems, and post-market surveillance of assay performance to build trust with government agencies and research institutions.

Furthermore, align product development with application-specific requirements by offering assay variants optimized for disease diagnosis, surveillance, research, and vaccine development, and ensure that surveillance-focused solutions address both active and passive surveillance workflows. Emphasize modularity and usability so veterinary hospitals and smaller clinics can implement assays with minimal infrastructure. Finally, fortify supply chain resilience through regional warehousing, alternate sourcing strategies for key reagents, and transparent contractual terms that clarify continuity commitments. By executing these priorities, industry leaders will not only improve market access but also support more effective and sustainable disease control programs.

Transparent mixed-methods research methodology detailing primary interviews, secondary validation and analytical frameworks used to derive practical insights on ELISA diagnostics adoption and deployment

This report synthesizes qualitative and primary research methodologies to ensure robust, defensible insights. Primary inputs derive from structured interviews with diagnostic laboratory directors, government surveillance managers, veterinary clinicians, and research scientists, supplemented by vendor briefings and distributor assessments to capture real-world procurement and logistical considerations. Secondary analysis integrates peer-reviewed literature, regulatory guidance documents, and technical validation reports to triangulate performance characteristics of Competitive, Indirect, and Sandwich ELISA formats.

Analytical approaches include comparative assay performance mapping, end-user requirement profiling, and distribution channel analysis, each designed to identify friction points in validation, adoption, and supply continuity. Where appropriate, case studies illustrate successful assay deployments, regulatory pathways, and distributor partnerships. Throughout the methodology, emphasis rests on reproducibility and transparency: interview protocols, inclusion criteria for public documents, and analytical assumptions are documented, and sensitivity checks ensure that qualitative conclusions remain consistent across stakeholder groups and regional contexts. This mixed-methods approach yields actionable findings grounded in empirical evidence and practitioner experience.

Concise concluding synthesis reinforcing the necessity for adaptive validation, supply chain resilience and collaborative deployment strategies to optimize ELISA-based ASFV antibody testing

In summary, antibody ELISA diagnostics for African Swine Fever Virus occupy a critical position within modern surveillance, diagnostic, and research ecosystems. The combination of advancing assay chemistries, shifting procurement dynamics, and region-specific regulatory realities demands that manufacturers, distributors, and end users adopt adaptive strategies that prioritize validation, supply continuity, and tailored support. Segmentation by test type, end user, application, and distribution channel clarifies where product differentiation and service enhancements will most effectively drive adoption, while regional nuance underscores the need for localized regulatory and logistics approaches. Moving from insight to implementation will require coordinated efforts among industry, government, and research institutions to ensure assays deliver reliable results within the operational constraints of diverse laboratory and field environments.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. ELISA Kit for Antibody Detection Against African Swine Fever Virus Market, by Product Type

  • 8.1. Indirect ELISA Kits
    • 8.1.1. IgG Antibody Detection
    • 8.1.2. Total Antibody Detection
  • 8.2. Blocking And Competitive ELISA Kits
    • 8.2.1. Monoclonal Antibody-Based
    • 8.2.2. Polyclonal Antibody-Based
  • 8.3. Double-Antigen Sandwich ELISA Kits

9. ELISA Kit for Antibody Detection Against African Swine Fever Virus Market, by Test Type

  • 9.1. Competitive Elisa
  • 9.2. Indirect Elisa
  • 9.3. Sandwich Elisa

10. ELISA Kit for Antibody Detection Against African Swine Fever Virus Market, by Sample Type

  • 10.1. Serum Samples
    • 10.1.1. Individual Animal Serum
    • 10.1.2. Pooled Serum
  • 10.2. Plasma Samples
  • 10.3. Whole Blood
  • 10.4. Oral Fluid
  • 10.5. Tissue Extracts

11. ELISA Kit for Antibody Detection Against African Swine Fever Virus Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Distributors
    • 11.2.1. International Distributors
    • 11.2.2. National Distributors
  • 11.3. Online

12. ELISA Kit for Antibody Detection Against African Swine Fever Virus Market, by Application

  • 12.1. Disease Diagnosis
  • 12.2. Research
  • 12.3. Surveillance
    • 12.3.1. Active Surveillance
    • 12.3.2. Passive Surveillance
  • 12.4. Vaccine Development

13. ELISA Kit for Antibody Detection Against African Swine Fever Virus Market, by End User

  • 13.1. Diagnostic Laboratories
    • 13.1.1. Private
    • 13.1.2. Public
  • 13.2. Government Agencies
  • 13.3. Research Institutions
  • 13.4. Veterinary Hospitals

14. ELISA Kit for Antibody Detection Against African Swine Fever Virus Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. ELISA Kit for Antibody Detection Against African Swine Fever Virus Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. ELISA Kit for Antibody Detection Against African Swine Fever Virus Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States ELISA Kit for Antibody Detection Against African Swine Fever Virus Market

18. China ELISA Kit for Antibody Detection Against African Swine Fever Virus Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abcam plc
  • 19.6. Adiagen, Inc.
  • 19.7. Bionote, Inc.
  • 19.8. Biosellal S.A.
  • 19.9. BioStone Animal Health LLC
  • 19.10. Boehringer Ingelheim Svanova
  • 19.11. Cusabio Biotech Co., Ltd.
  • 19.12. Gold Standard Diagnostics, Inc.
  • 19.13. ID.vet Innovative Diagnostics
  • 19.14. IDEXX Laboratories, Inc.
  • 19.15. Indical Bioscience GmbH
  • 19.16. J&G Biotech Ltd.
  • 19.17. Merck KGaA
  • 19.18. R&D Systems, Inc.
  • 19.19. Tetracore, Inc.
  • 19.20. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIRECT ELISA KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIRECT ELISA KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIRECT ELISA KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIRECT ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY IGG ANTIBODY DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY IGG ANTIBODY DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY IGG ANTIBODY DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TOTAL ANTIBODY DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TOTAL ANTIBODY DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TOTAL ANTIBODY DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY BLOCKING AND COMPETITIVE ELISA KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY BLOCKING AND COMPETITIVE ELISA KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY BLOCKING AND COMPETITIVE ELISA KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY BLOCKING AND COMPETITIVE ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY MONOCLONAL ANTIBODY-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY MONOCLONAL ANTIBODY-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY MONOCLONAL ANTIBODY-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY POLYCLONAL ANTIBODY-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY POLYCLONAL ANTIBODY-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY POLYCLONAL ANTIBODY-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DOUBLE-ANTIGEN SANDWICH ELISA KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DOUBLE-ANTIGEN SANDWICH ELISA KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DOUBLE-ANTIGEN SANDWICH ELISA KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY COMPETITIVE ELISA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY COMPETITIVE ELISA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY COMPETITIVE ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIRECT ELISA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIRECT ELISA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIRECT ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SANDWICH ELISA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SANDWICH ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SERUM SAMPLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SERUM SAMPLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SERUM SAMPLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SERUM SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIVIDUAL ANIMAL SERUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIVIDUAL ANIMAL SERUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIVIDUAL ANIMAL SERUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY POOLED SERUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY POOLED SERUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY POOLED SERUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PLASMA SAMPLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PLASMA SAMPLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PLASMA SAMPLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY ORAL FLUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY ORAL FLUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY ORAL FLUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TISSUE EXTRACTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TISSUE EXTRACTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TISSUE EXTRACTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INTERNATIONAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INTERNATIONAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INTERNATIONAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISEASE DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISEASE DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SURVEILLANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SURVEILLANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SURVEILLANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY ACTIVE SURVEILLANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY ACTIVE SURVEILLANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY ACTIVE SURVEILLANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PASSIVE SURVEILLANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PASSIVE SURVEILLANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PASSIVE SURVEILLANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY VACCINE DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY VACCINE DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PUBLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY GOVERNMENT AGENCIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY GOVERNMENT AGENCIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY GOVERNMENT AGENCIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIRECT ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY BLOCKING AND COMPETITIVE ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SERUM SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIRECT ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY BLOCKING AND COMPETITIVE ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SERUM SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIRECT ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY BLOCKING AND COMPETITIVE ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SERUM SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIRECT ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY BLOCKING AND COMPETITIVE ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SERUM SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIRECT ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY BLOCKING AND COMPETITIVE ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SERUM SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIRECT ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY BLOCKING AND COMPETITIVE ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SERUM SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIRECT ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY BLOCKING AND COMPETITIVE ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SERUM SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY INDIRECT ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY BLOCKING AND COMPETITIVE ELISA KITS, 2018-2032 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY SERUM SAMPLES, 2018-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC ELISA KIT FOR ANTIBODY DETECTION AGAINST AFRICAN SWINE FEVER VIRUS MARKET SIZE, B